Yahoo
As the United States market experiences a tech rally led by chip stocks, with indices like the S&P 500 and Nasdaq showing gains, investors are keenly watching for opportunities in various segments. Penny stocks, though an older term, continue to represent smaller or less-established companies that might offer significant value. By focusing on those with strong financial fundamentals and potential growth trajectories, investors can uncover promising opportunities among these often-overlooked...
SeekingAlpha
MacroGenix faces financial challenges with uncertain revenues and high expenses, leading to a 33% stock drop and limited appeal for new investors. Click to read.
Yahoo
ROCKVILLE, MD, Dec. 02, 2024 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conference this month: 7th Annual Evercore HealthCONx (Coral Gables, FL). MacroGenics’ President and Chief Executive Officer, Scott Koenig, M.D., Ph
Yahoo
As November 2024 comes to a close, the U.S. stock market is celebrating record highs with the S&P 500 and Dow Jones Industrial Average posting their biggest monthly gains of the year. For investors willing to explore beyond large-cap stocks, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities. Despite being considered a relic by some, these stocks can still provide significant potential when backed by strong financials, making them an...
Yahoo
MacroGenics ( NASDAQ:MGNX ) Third Quarter 2024 Results Key Financial Results Revenue: US$110.7m (up by US$100.3m from...
Yahoo
ROCKVILLE, MD, Nov. 06, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conferences this month: Guggenheim Securities Healthcare Innovation Conference (Boston). MacroGenics’ Chief Operating Officer, Eric Risser, will participate in a fi
Current Value
$3.291 Year Return
Current Value
$3.291 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CION | -<0.01% | - | - | 13.00% |
AEM | 0.01% | $41.81B | +60.12% | 1.89% |
UI | -0.02% | $21.59B | +170.18% | 0.68% |
AFL | 0.02% | $57.54B | +25.33% | 1.98% |
PEG | 0.03% | $42.49B | +37.53% | 2.84% |
PULM | 0.04% | $21.88M | +193.63% | 0.00% |
CENX | 0.05% | $1.79B | +70.16% | 0.00% |
SJM | 0.06% | $11.22B | -18.59% | 4.21% |
VOD | -0.07% | $20.92B | -6.49% | 9.06% |
AS | -0.07% | $16.68B | +134.85% | 0.00% |
TPB | -0.07% | $999.17M | +122.58% | 0.51% |
PM | -0.09% | $189.47B | +28.99% | 4.46% |
CNTY | 0.09% | $90.51M | -33.11% | 0.00% |
BLCO | 0.10% | $6.37B | +17.71% | 0.00% |
SCHW | -0.10% | $129.92B | +10.91% | 1.38% |
FRPT | 0.12% | $7.10B | +71.66% | 0.00% |
NTIC | -0.13% | $127.19M | +9.19% | 2.13% |
CBOE | -0.13% | $20.20B | +9.90% | 1.22% |
FTNT | -0.16% | $73.61B | +56.49% | 0.00% |
HCI | 0.16% | $1.21B | +32.80% | 1.45% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FAT | 47.59% | $91.08M | -15.20% | 10.51% |
SLF | 39.91% | $33.70B | +14.32% | 4.14% |
COLL | 38.47% | $1.08B | +2.18% | 0.00% |
AKAM | 38.40% | $14.03B | -19.57% | 0.00% |
LAW | 37.87% | $294.15M | -40.41% | 0.00% |
OKLO | 35.62% | $3.19B | +145.95% | 0.00% |
SKLZ | 33.65% | $94.54M | -2.93% | 0.00% |
ALLO | 33.45% | $492.73M | -25.87% | 0.00% |
XPOF | 33.28% | $473.97M | +23.36% | 0.00% |
DNOW | 33.25% | $1.37B | +27.68% | 0.00% |
YELP | 33.20% | $2.57B | -12.08% | 0.00% |
CRSP | 33.04% | $3.52B | -34.81% | 0.00% |
CERS | 32.54% | $302.72M | -19.31% | 0.00% |
DIOD | 32.28% | $3.01B | -12.17% | 0.00% |
ARWR | 32.02% | $2.46B | -49.94% | 0.00% |
BHVN | 31.82% | $3.96B | -15.76% | 0.00% |
SSP | 31.65% | $215.91M | -68.11% | 0.00% |
ZIP | 31.53% | $665.35M | -53.29% | 0.00% |
IOVA | 31.53% | $2.19B | -23.32% | 0.00% |
FATBB | 30.71% | $80.25M | -14.94% | 11.99% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MTD | -25.40% | $26.30B | +5.92% | 0.00% |
NVAX | -24.75% | $1.54B | +98.45% | 0.00% |
ITOS | -23.99% | $285.33M | -28.08% | 0.00% |
NNI | -22.10% | $3.85B | +27.09% | 1.09% |
GEN | -19.64% | $16.71B | +18.80% | 1.87% |
ORGO | -18.09% | $393.52M | -23.28% | 0.00% |
ADMA | -17.22% | $4.39B | +274.19% | 0.00% |
IAG | -15.18% | $3.23B | +136.40% | 0.00% |
WLKP | -14.87% | $810.49M | +4.03% | 8.12% |
PSN | -14.02% | $9.75B | +44.75% | 0.00% |
GAN | -13.81% | $84.30M | +18.59% | 0.00% |
OBDE | -13.75% | $1.77B | -1.18% | 7.42% |
INSG | -12.61% | $168.45M | +449.54% | 0.00% |
GRVY | -12.55% | $431.46M | -13.42% | 0.00% |
CTLP | -12.00% | $636.44M | +22.64% | 0.00% |
HRB | -11.98% | $7.44B | +17.73% | 2.60% |
CDNA | -11.87% | $1.29B | +95.28% | 0.00% |
SG | -11.54% | $3.73B | +202.35% | 0.00% |
ACIC | -11.21% | $593.89M | +28.98% | 0.00% |
MNOV | -10.90% | $97.60M | +33.11% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TPMN | -11.98% | $41.62M | 0.65% |
DBA | -11.80% | $794.04M | 0.93% |
VIXY | -10.94% | $195.31M | 0.85% |
CTA | -10.25% | $483.80M | 0.76% |
WEAT | -8.22% | $119.67M | 0.28% |
USDU | -7.68% | $379.83M | 0.5% |
USCI | -6.53% | $194.60M | 1.07% |
CORN | -6.53% | $63.58M | 0.2% |
VRIG | -5.59% | $1.13B | 0.3% |
EQLS | -5.54% | $8.97M | 1% |
FTGC | -5.24% | $2.24B | 1.02% |
BCI | -5.19% | $1.31B | 0.26% |
DBC | -5.09% | $1.31B | 0.87% |
CMDY | -5.00% | $282.97M | 0.28% |
AGZD | -4.59% | $142.56M | 0.23% |
PDBC | -4.58% | $4.17B | 0.59% |
KMLM | -4.53% | $334.70M | 0.9% |
TAIL | -3.68% | $65.56M | 0.59% |
DBE | -3.51% | $48.32M | 0.77% |
COMT | -3.50% | $694.40M | 0.48% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CANE | -0.02% | $12.08M | 0.29% |
PHDG | 0.02% | $115.49M | 0.39% |
URNM | -0.03% | $1.55B | 0.75% |
SOYB | -0.09% | $24.83M | 0.22% |
IVOL | -0.13% | $451.42M | 1.02% |
YLD | 0.14% | $273.52M | 0.39% |
MUST | 0.19% | $423.07M | 0.23% |
BLCN | 0.21% | $63.42M | 0.68% |
FTXG | -0.22% | $22.63M | 0.6% |
TBLL | -0.23% | $2.00B | 0.08% |
IYK | 0.24% | $1.22B | 0.4% |
FLTR | 0.29% | $1.95B | 0.14% |
SEIX | 0.41% | $300.05M | 0.62% |
MSOS | -0.54% | $505.06M | 0.83% |
HYMU | 0.55% | $255.43M | 0.35% |
UNG | 0.80% | $746.57M | 1.06% |
CLOI | 0.94% | $792.56M | 0.4% |
JUCY | -0.97% | $301.67M | 0.6% |
COPX | 1.05% | $2.66B | 0.65% |
EIS | -1.10% | $224.90M | 0.59% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 32.52% | $6.39B | 0.35% |
XPH | 29.73% | $158.74M | 0.35% |
ARKG | 29.14% | $1.16B | 0.75% |
GNOM | 28.81% | $71.12M | 0.5% |
IBB | 27.94% | $6.59B | 0.45% |
PBE | 27.53% | $251.02M | 0.58% |
IHE | 26.58% | $602.79M | 0.39% |
IWC | 25.93% | $965.33M | 0.6% |
RSPA | 25.77% | $270.13M | 0% |
BBH | 25.73% | $404.15M | 0.35% |
IWO | 25.10% | $12.83B | 0.24% |
IWM | 24.37% | $72.22B | 0.19% |
XHE | 24.27% | $219.66M | 0.35% |
VTWO | 24.22% | $12.40B | 0.1% |
FBT | 23.92% | $1.13B | 0.56% |
PRFZ | 23.71% | $2.56B | 0.39% |
EDOC | 23.27% | $38.96M | 0.68% |
GSSC | 23.24% | $529.38M | 0.2% |
ARKK | 23.03% | $6.35B | 0.75% |
PTH | 22.95% | $122.57M | 0.6% |